Stock Events

Stock Events

Avenue Therapeutics (ATXI) Q3 2024 Earnings

9AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-15.4

-10.08

-4.76

0.56

Details

Expected EPS

-1.05

Actual EPS

-6.43

Surprise EPS

-5.38

Surprise Percent

+512.38%

Description

Avenue Therapeutics (ATXI) has reported earnings of -6.43 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.